GenMark Shares Rise on Acquisition Rumors

Feb 11, 2021

|

NEW YORK ─ GenMark Diagnostics' shares rose 27 percent to $21.47 in Thursday morning trading on the Nasdaq following a report that it has been approached by potential acquirers.

Investors went on a buying spree after Bloomberg, citing unnamed sources, reported Wednesday evening that Carlsbad, California-based GenMark is working with a financial advisor on a potential sale.

GenMark told 360Dx that in accordance with its policy, it doesn't comment on rumors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

P.1 Re-infection Concerns

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

Aiming for May

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

NIH Program to Address Structural Racism

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

PNAS Papers on Myelopathy GWAS in Japan, Hypertrophic Cardiomyopathy, MRSA Methylation

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.

Featured White Papers

PCR Diagnostic Kits & Freeze-Drying Considerations

Nucleic Acid Contamination Application Ebook

Multisite Evaluation of a Single-tube SMN1/2 PCR/CE Assay System that Assesses Copy Number and Expanded Content for Spinal Muscular Atrophy

Verification of a Single-tube PCR/CE Kit for SMN1/2 Copy Number and Variants Associated with Gene Duplication and SMA Disease Severity

Mar

11

Featured Webinar

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

In this session, the third in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified gene fusions that may or may not serve as druggable targets.

Mar

16

Featured Webinar

The Predictive Power of Poop: COVID-19 Wastewater Surveillance to Inform Public Health Decisions in Colorado

Wastewater based epidemiology (WBE) has been established as a viable, valuable, and cost-effective means to monitor infectious disease within a community.

Mar

18

Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Viruses mutate as they strive to thrive in response to selective pressures.

Mar

25

Featured Webinar

Virtual Molecular Tumor Board Series: What to Do with a ‘Negative’ Molecular Panel Case

In this session, the fourth in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling identified no clear molecular markers to help guide personalized therapy.

Menu

GenMark Shares Rise on Acquisition Rumors

To read the full story....

Breaking News

Human Pangenome Reference Consortium Releases Data From 30 Genomes

MDxHealth 2020 Revenues Up 57 Percent

Quanterix Q4 Revenues Up 64 Percent

NIH, Partners Commit $74.9M to New Phase of Alzheimer's Program

Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent

Twist Bioscience, Watchmaker Genomics Partner on High-Throughput NGS Applications

The Scan

P.1 Re-infection Concerns

Aiming for May

NIH Program to Address Structural Racism

PNAS Papers on Myelopathy GWAS in Japan, Hypertrophic Cardiomyopathy, MRSA Methylation

Featured White Papers

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

The Predictive Power of Poop: COVID-19 Wastewater Surveillance to Inform Public Health Decisions in Colorado

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Virtual Molecular Tumor Board Series: What to Do with a ‘Negative’ Molecular Panel Case

What's Popular?

Hologic Acquires European MDx Firm Diagenode for Approximately $159M

FDA Grants Emergency Use Authorization for University of Illinois Coronavirus PCR Test

Luminex Shares Surge on Rumor of Acquisition by DiaSorin

William Blair Initiates Coverage of Point-of-Care MDx Firm Lucira Health With Outperform Rating

OraSure Technologies Q4 Revenues Rise 27 Percent, Beat Analysts' Estimate

Sponsorships